What is Prometheus? It is a startup company launched by Amazon’s Jeff Bezos late last year. The goal is to develop an AI tool ...
Zacks Investment Research on MSN
Merck's anti-TL1A antibody meets goal in ulcerative colitis study
Merck MRK announced positive results from Study 2 of the late-stage ATLAS-UC study, which evaluated tulisokibart, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results